These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15488347)

  • 1. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women.
    Mueck AO; Seeger H
    Maturitas; 2004 Nov; 49(3):189-203. PubMed ID: 15488347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C; Dinçer Cengiz S; Cengiz B; Akgün G
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
    Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
    Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
    Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
    Karalis I; Beevers G; Beevers M; Lip G
    Blood Press; 2005; 14(1):38-44. PubMed ID: 15823946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and blood pressure in hypertensive women.
    Lip GY; Beevers M; Churchill D; Beevers DG
    J Hum Hypertens; 1994 Jul; 8(7):491-4. PubMed ID: 7932511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
    White WB; Pitt B; Preston RA; Hanes V
    Circulation; 2005 Sep; 112(13):1979-84. PubMed ID: 16186434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C; Cengiz SD; Cengiz B; Akgun G
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do clinicians prescribe HRT for hypertensive postmenopausal women?
    Lip G; Beevers M; Churchill D; Beevers DG
    Br J Clin Pract; 1995; 49(2):61-4. PubMed ID: 7779644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
    Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondipping status does not attenuate the conjugated estrogen-induced improvement in aortic stiffness in postmenopausal women with untreated hypertension.
    Tsioufis C; Tzioumis K; Dimitriadis K; Chatzis D; Skiadas I; Michailidis A; Toutouzas P; Kallikazaros I; Stefanadis C
    Am J Hypertens; 2005 May; 18(5 Pt 1):607-11. PubMed ID: 15882542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.